Antihypertensive drugs that have targets the reninangiotensin system, does pulmonary ACE2 levels, thus favoring a greater entry of SARS COV-2?
- Funded by Ministerio de Ciencia, Tecnología e Innovación [Ministry of Science, Technology and Innovation] (MINCYT)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$6,125.21Funder
Ministerio de Ciencia, Tecnología e Innovación [Ministry of Science, Technology and Innovation] (MINCYT)Principal Investigator
MARIELA GIRONACCIResearch Location
ArgentinaLead Research Institution
Universidad de Buenos AiresResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified